Insider · CIK 0001181174
DORSA CAROLINE
Reports to the SEC for 9 companies · SAN DIEGO, CA
Transactions
50
Companies
9
Filings
17
CIK
0001181174
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-21 | ILMNILLUMINA, INC.A Award | +$300K |
| 2026-05-20 | ILMNILLUMINA, INC.F Tax Payment | −$215K |
| 2026-05-07 | DUKDuke Energy CORPA Award | +$200K |
| 2025-06-17 | BIIBBIOGEN INC.A Award | — |
| 2025-05-21 | ILMNILLUMINA, INC.A Award | — |
| 2025-05-16 | ILMNILLUMINA, INC.F Tax Payment | −$89.5K |
| 2025-05-02 | BIIBBIOGEN INC.P Purchase | +$152K |
| 2025-05-01 | DUKDuke Energy CORPA Award | +$195K |
| 2024-06-21 | BIIBBIOGEN INC.A Award | — |
| 2024-05-16 | ILMNILLUMINA, INC.A Award | — |
| 2024-05-15 | ILMNILLUMINA, INC.F Tax Payment | −$70.4K |
| 2024-05-09 | DUKDuke Energy CORPA Award | +$175K |
| 2023-06-26 | BIIBBIOGEN INC.A Award | — |
| 2023-05-26 | ILMNILLUMINA, INC.A Award | — |
| 2023-05-24 | ILMNILLUMINA, INC.F Tax Payment | −$105K |
| 2023-05-04 | DUKDuke Energy CORPA Award | +$175K |
| 2022-06-15 | BIIBBIOGEN INC.A Award | — |
| 2022-06-14 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-14 | NTLAIntellia Therapeutics, Inc.A Award | — |
| 2022-05-26 | ILMNILLUMINA, INC.A Award | — |
| 2022-05-25 | ILMNILLUMINA, INC.F Tax Payment | −$85.3K |
| 2022-05-05 | DUKDuke Energy CORPA Award | +$175K |
| 2021-07-01 | BIIBBIOGEN INC.A Award | — |
| 2021-06-23 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-06-23 | NTLAIntellia Therapeutics, Inc.A Award | — |
| 2021-06-10 | ILMNILLUMINA, INC.S Sale | −$450K |
| 2021-05-26 | ILMNILLUMINA, INC.A Award | — |
| 2021-05-25 | ILMNILLUMINA, INC.F Tax Payment | −$153K |
| 2021-05-06 | DUKDuke Energy CORPA Award | +$160K |
| 2021-04-05 | NTLAIntellia Therapeutics, Inc.S Sale | −$386K |
| 2021-04-05 | NTLAIntellia Therapeutics, Inc.S Sale | −$164K |
| 2021-04-05 | NTLAIntellia Therapeutics, Inc.S Sale | −$66.4K |
| 2021-04-05 | NTLAIntellia Therapeutics, Inc.M Exercise/Conversion | +$48K |
| 2021-04-05 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-06-18 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2020-06-03 | BIIBBIOGEN INC.A Award | — |
| 2020-05-27 | ILMNILLUMINA, INC.A Award | — |
| 2020-05-26 | ILMNILLUMINA, INC.F Tax Payment | −$184K |
| 2019-06-19 | BIIBBIOGEN INC.A Award | — |
| 2019-05-29 | ILMNILLUMINA, INC.A Award | — |
| 2019-05-23 | ILMNILLUMINA, INC.F Tax Payment | −$182K |
| 2019-05-21 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-12 | BIIBBIOGEN INC.A Award | — |
| 2018-05-23 | ILMNILLUMINA, INC.A Award | — |
| 2018-05-22 | ILMNILLUMINA, INC.F Tax Payment | −$250K |
| 2018-05-17 | NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-03-23 | NTLAIntellia Therapeutics, Inc.A Award | +$9,860.5 |
| 2017-06-07 | BIIBBIOGEN INC.A Award | — |
| 2017-06-02 | NTLAIntellia Therapeutics, Inc.A Award | +$62.1K |
| 2017-05-30 | ILMNILLUMINA, INC.A Award | — |
Recent filings
- 4DORSA CAROLINE0001110803-26-000114SEC(opens sec.gov)
- 4DORSA CAROLINE0001181174-26-000002SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-25-017756SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-25-015514SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-25-015017SEC(opens sec.gov)
- 4DORSA CAROLINE0001326160-25-000134SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-25-013345SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-24-019231SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-24-015934SEC(opens sec.gov)
- 4DORSA CAROLINE0001326160-24-000134SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-23-019541SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-23-017235SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-23-016870SEC(opens sec.gov)
- 4DORSA CAROLINE0001326160-23-000139SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-22-017776SEC(opens sec.gov)
- 4DORSA CAROLINE0001209191-22-037595SEC(opens sec.gov)
- 4DORSA CAROLINE0001127602-22-015918SEC(opens sec.gov)
Companies
- AVAYA INCSVP & Chief Financial Officer
- BIOGEN INC.DirectorBIIB
- Duke Energy CORPDirectorDUK
- GOLDMAN SACHS MLP & ENERGY RENAISSANCE FUNDTrustee
- Goldman Sachs MLP Income Opportunities FundDirector
- ILLUMINA, INC.DirectorILMN
- Intellia Therapeutics, Inc.DirectorNTLA
- MERCK SHARP & DOHME LLCV.P. & Treasurer
- PUBLIC SERVICE ENTERPRISE GROUP INCExecutive VP & CFOPEG
Address
5200 ILLUMINA WAY
SAN DIEGO, CA, 92122